← FDA Drug Approvals (Drugs@FDA)

SILDENAFIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2025-03-06

Drug application

FDA Application #

ANDA202954

Application type

Abbreviated New Drug Application (Generic)

Brand name

SILDENAFIL CITRATE

Generic name

SILDENAFIL

Active ingredients

SILDENAFIL CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

JUBILANT GENERICS

Manufacturer

Jubilant Cadista Pharmaceuticals Inc.

First approval

2025-03-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown